The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis

Figure 8

Forest plot comparing serum VEGF levels between MM patients after two courses of T-VAD treatment and nontumor controls.